Venetoclax with decitabine or azacitidine in previously untreated TP53mut acute myeloid leukemia

被引：0
|
作者：
Zacholski, Kyle
Bouligny, Ian Michael
Murray, Graeme
Patel, Tilak
Doyel, Michael
Boron, Josh
Tran, Valerie
Gor, Juhi
Hang, Yiwei
Thuy Ho
Venn, Chad Michael
Alnimer, Yanal Mufeed
Wages, Nolan
Grant, Steven
Maher, Keri Renee
机构：
[1] VCU, Massey Canc Ctr, Richmond, VA USA
[2] VCU, Sch Med, Richmond, VA USA
[3] VCU, Dept Internal Med, Richmond, VA USA
[4] Virginia Commonwealth Univ, Richmond, VA USA
[5] VCU, Dept Biostat, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19051
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FLAG-IDA or venetoclax in previously treated TP53mut acute myeloid leukemia
    Tran, Valerie
    Bouligny, Ian Michael
    Murray, Graeme
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Gor, Juhi
    Hang, Yiwei
    Ho, Thuy
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
    DiNardo, C. D.
    Jonas, B. A.
    Pullarkat, V.
    Thirman, M. J.
    Garcia, J. S.
    Wei, A. H.
    Konopleva, M.
    Doehner, H.
    Letai, A.
    Fenaux, P.
    Koller, E.
    Havelange, V.
    Leber, B.
    Esteve, J.
    Wang, J.
    Pejsa, V.
    Hajek, R.
    Porkka, K.
    Illes, A.
    Lavie, D.
    Lemoli, R. M.
    Yamamoto, K.
    Yoon, S. -S.
    Jang, J. -H.
    Yeh, S. -P.
    Turgut, M.
    Hong, W. -J.
    Zhou, Y.
    Potluri, J.
    Pratz, K. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07): : 617 - 629
  • [3] Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia
    Bouligny, Ian M.
    Murray, Graeme
    Ho, Thuy
    Doyel, Michael
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Wages, Nolan A.
    Grant, Steven
    Maher, Keri R.
    LEUKEMIA RESEARCH, 2023, 134
  • [4] Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax
    Kim, Kunhwa
    Maiti, Abhishek
    Loghavi, Sanam
    Pourebrahim, Rasoul
    Kadia, Tapan M.
    Rausch, Caitlin R.
    Furudate, Ken
    Daver, Naval G.
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas J.
    Takahashi, Koichi
    Yilmaz, Musa
    Tang, Guilin
    Ravandi, Farhad
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    CANCER, 2021, 127 (20) : 3772 - 3781
  • [5] Outcomes of TP53-Mutant Acute Myeloid Leukemia with Venetoclax and Decitabine
    Kim, Kunhwa
    Maiti, Abhishek
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Pemmaraju, Naveen
    Borthakur, Gautam
    Bose, Prithviraj
    Issa, Ghayas C.
    Short, Nicholas J.
    Yilmaz, Musa
    Alvarado, Yesid
    Ferrajoli, Alessandra
    Jabbour, Elias
    Jain, Nitin
    Ohanian, Maro
    Takahashi, Koichi
    Thompson, Philip A.
    Rausch, Caitlin R.
    Montalbano, Kathryn
    Pierce, Sherry A.
    Patel, Keyur P.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina
    BLOOD, 2020, 136
  • [6] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [7] Efficacy of Hypomethylating Agents with Venetoclax in TP53mut AML
    Bouligny, Ian M.
    Murray, Graeme
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Maher, Keri
    BLOOD, 2022, 140 : 11842 - 11843
  • [8] Treatment Initiation of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in Patients with Untreated Acute Myeloid Leukemia
    Manda, Sudhir
    Anz, Bertrand
    Benton, Christopher
    Broun, E. Randolph
    Yimer, Habte
    Renshaw, John
    Geils, George F.
    Cruz, Jose
    Fanning, Suzanne
    Melear, Jason
    Sharman, Jeff P.
    Kang, Kingston
    Svensson, Anders
    Pai, Madhavi
    Donnellan, William
    BLOOD, 2021, 138
  • [9] Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia
    Patel, Kishan K.
    Zeidan, Amer M.
    Shallis, Rory M.
    Prebet, Thomas
    Podoltsev, Nikolai
    Huntington, Scott F.
    BLOOD ADVANCES, 2021, 5 (04) : 994 - 1002
  • [10] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
12345